Abstract:
New immunological carrier systems, DNA encoding the same, and the use of these systems, are disclosed. The carrier systems include chimeric proteins which include a leukotoxin polypeptide fused to one or more selected GnRH multimers which comprise at least one repeating GnRH decapeptide sequence, or at least one repeating unit of a sequence corresponding to at least one epitope of a selected GnRH molecule. Under the invention, the selected GnRH sequences may all be the same, or may correspond to different derivatives, analogues, variants or epitopes of GnRH so long as the GnRH sequences are capable of eliciting an immune response. The leukotoxin functions to increase the immunogenicity of the GnRH multimers fused thereto.
Abstract:
Advantage is taken of the ability of rotaviral VP6 protein to home to macrophage and monocytes to provide label to these cells in either an in vitro or in vivo environment. Further, the ability to couple label to the VP6 protein and to couple VP6 to a targeting agent provides a mechanism for conducting label (or an effector moiety) to any desired target.
Abstract:
A heat exchange process and apparatus are especially suited for use in heat recovery applications, especially in a run-around heat exchanger. The run-around heat recovery system has two liquid to gas heat echangers (10, 12), one for heat transfer with stale air being exhausted and one for heat transfer with fresh air being taken in. The two heat exchangers (10, 12) are linked with a common coupling liquid so that heat may be extracted from one of the air flows and added to the other. To improve the heat transfer process, a gas is injected into the liquid just before it enters one or both of the heat exchangers. The resultant mixed phase flow produces a much higher heat transfer coefficient in the heat exchangers (10, 12), yielding a significant improvement in the system performance.
Abstract:
Compositions and methods for modulating SRIF activity as well as enhancing the reproductive performance and immunological function in vertebrates are disclosed. Compositions containing SRIF-related peptides or antibodies thereto can be administered to animals to modulate endogenous SRIF-like activity. The SRIF-related peptides can be linked to a carrier such as ovalbumin, and administered in an Al(OH)3 adjuvant, to enhance the immunogenicity of the SRIF-related peptides.
Abstract:
The CAMP factor gen of Streptococcus uberis (S. uberis) is described, as well as the recombinant production of CAMP factor therefrom. CAMP factors can be used in vaccine compositions for the prevention and treatment of bacterial infections.
Abstract:
A crop harvester has bristle guards (39) mounted on the cutter bar (14) as crop lifters and to capture fruit lost by dehiscence during cutting. Each bristle guard is a set of laterally oriented bristles (44). Dehisced fruit is swept into the header by a pickup reel (16) having bristle bats (74). The bristles (76) are supported on the leading side by a strip (78) of flexible belting. The belting protects the bristle bats against being cut by the cutter bar. The crops are supported against being pushed forward by the bristle bats (74) of the reel. The reel diameter is reduced to about one-half normal and the reel index is increased to provide an aggressive reel operation, ensuring that plants are properly engaged in the bristle guards for cutting.
Abstract:
The present invention relates to novel live bovine adenovirus (BAV) expression vector systems in which part or all of one or both of the early region 1 (E1) and early region 3 (E3) genes are deleted and replaced by a foreign gene or fragment thereof and novel recombinant mammalian cell lines stably transformed with BAV E1 sequences, and therefore, express E1 gene products capable of allowing replication therein of a bovine adenovirus having an E1 deletion replaced by a heterologous nucleotide sequence encoding a foreign gene or fragment thereof and their use in production of (antigenic) polypeptides or fragments thereof for the purpose of live recombinant virus or subunit vaccine or for other therapies.
Abstract:
Vaccines are provided for vaccinating an animal against pathogenic bacteria, including E. coli. The invention also encompasses methods of preparing and methods of use of vaccine strains and compositions that result from or are used in these methods.
Abstract:
A desiccated mature gymnosperm somatic embryo characterized by having a moisture content which is lower than the moisture content of its corresponding zygotic embryo and a dry weight and per embryo lipid content which are higher than the lipid content and dry weight of its corresponding gymnosperm zygotic embryo. Preferred desiccated gymnosperm somatic embryos are conifer somatic embryos having a moisture content ranging between 10 and 55 %. Also within the scope of the invention is a method for producing desiccated somatic embryos. The method comprises developing immature embryos in a medium comprising at least one non-permeating water stress agent, a metabolizable carbon source and a growth regulator having an influence on embryo development for a period of time sufficient to yield the recovery of mature somatic embryos having a moisture content which is lower than the moisture content of corresponding zygotic embryos. The method can optionally include a secondary desiccation treatment to further reduce the moisture content of the embryos.
Abstract:
The present invention relates to novel primitive cell colony stimulating factors (PC-CSFs) and active fragments thereof, derived from non-adherent (NA) bone marrow cells. These factors are useful for treating disorders of the hematopoietic system. Antibodies directed against epitopes specific for PC-CSF can be used to purify PC-CSF, as well as for diagnosis of hematopoietic disorders.